ASTRIA THERAPEUTICS Trademark

Trademark Overview

On Thursday, June 3, 2021, a trademark application was filed for ASTRIA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ASTRIA THERAPEUTICS trademark a serial number of 90751659. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, October 8, 2025. This trademark is owned by Catabasis Pharmaceuticals, Inc.. The ASTRIA THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of allergic and inflammatory diseases and disorders; all of the foregoing do not contain cannabis, hemp, or derivatives thereof
astria therapeutics

General Information

Serial Number90751659
Word MarkASTRIA THERAPEUTICS
Filing DateThursday, June 3, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, October 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2024

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of allergic and inflammatory diseases and disorders; all of the foregoing do not contain cannabis, hemp, or derivatives thereof
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 25, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameASTRIA THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameASTRIA THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02109
Party NameCatabasis Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02110

Trademark Events

Event DateEvent Description
Wednesday, June 16, 2021TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, February 18, 2022ASSIGNED TO EXAMINER
Monday, June 7, 2021NEW APPLICATION ENTERED
Wednesday, June 16, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, August 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 6, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, February 23, 2022NON-FINAL ACTION E-MAILED
Wednesday, February 23, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 2, 2022SUSPENSION LETTER WRITTEN
Tuesday, August 2, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, August 2, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, October 7, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 23, 2022NON-FINAL ACTION WRITTEN
Wednesday, July 20, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 7, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 20, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, April 6, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, December 20, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, January 17, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 31, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 20, 2024PUBLISHED FOR OPPOSITION
Wednesday, January 31, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, June 6, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 16, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 6, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 11, 2024SOU EXTENSION 1 FILED
Friday, October 11, 2024SOU TEAS EXTENSION RECEIVED
Friday, October 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 11, 2024SOU EXTENSION 1 GRANTED
Monday, April 7, 2025SOU TEAS EXTENSION RECEIVED
Monday, April 7, 2025SOU EXTENSION 2 FILED
Wednesday, October 8, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, October 8, 2025SOU EXTENSION 3 FILED
Wednesday, October 8, 2025SOU EXTENSION 3 GRANTED
Thursday, October 9, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 8, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 7, 2025SOU EXTENSION 2 GRANTED

Related Keywords

therapeutics astria cannabis contain hemp derivatives thereof foregoing disorders treatment allergic inflammatory